STOCKHOLM – ADDvise Group, a supplier of equipment to health care and research facilities, has entered into a share purchase agreement with the owners of Diabetic Supplies Inc. to acquire all shares of the company. ADDvise Group will acquire Diabetes Supplies for an initial cash purchase price of $9.5 million, with two potential earn-outs of a total of $5.1 million, providing that Diabetic Supplies achieves certain determined financial targets. Diabetic Supplies’ revenue for the 12 months ended June 30, 2023, was $8.1 million, with an EBITDA of $3.3 million, corresponding to an EBITDA margin of 40.4%. ADDvise will fund the acquisition through its own funds and existing credit facilities. It believes the acquisition will have a positive impact on its earnings per share during the financial year 2023. ADDvise Group expects to close the acquisition at the beginning of September 2023.
In 2023, the M&A market for healthcare companies continues to build on STRATEGIC opportunities in the current market. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
